katrina4384Feb 26, 20220 min readSage Therapeutics - The FDA has granted Fast Track Designation to SAGE-718.Updated: Mar 31, 2022
Myth or Fact: People with Psychiatric Symptoms in Huntington's Disease Won't Have Involuntary Movement
Prilenia filed a European Marketing Authorization Application (MAA) with the EMA. What's next for the United States?
Kommentare